Atypical haemolytic uraemic syndrome: a case of rare genetic mutation

2021 ◽  
Vol 14 (7) ◽  
pp. e244190
Author(s):  
Geminiganesan Sangeetha ◽  
Jaippreetha Jayaraj ◽  
Swathi Ganesan ◽  
Sreeapoorva Puttagunta

Complement-mediated kidney disease has been an evolving area in the field of nephrology. Atypical haemolytic uraemic syndrome (aHUS) is a rare thrombotic microangiopathy that affects multiple organs, particularly kidneys. The disease is characterised by a triad of haemolytic anaemia, thrombocytopenia and acute kidney injury (AKI). aHUS is most commonly caused by dysregulation of alternative complement pathway. In contrast to shiga toxin-associated haemolytic uraemic syndrome, diarrheal prodrome is usually absent in children with aHUS. We report a 2-year, 9-month-old boy who presented with acute dysentery and AKI. He had an unusual prolonged course of illness with hypocomplementaemia; hence, genetic testing was performed. He had a storming course in the hospital and succumbed to complications of the disease. Genetic study revealed digenic mutation in Complement Factor I and C3. Therefore, it is important to differentiate aHUS from other thrombotic microangiopathies to improve the outcome.

2008 ◽  
Vol 45 (16) ◽  
pp. 4131
Author(s):  
Sara C. Nilsson ◽  
Leendert A. Trouw ◽  
Bruno O. Villoutreix ◽  
Veronique Fremeaux-Bacchi ◽  
Anna M. Blom

Immunobiology ◽  
2016 ◽  
Vol 221 (10) ◽  
pp. 1124-1130 ◽  
Author(s):  
Patrick J. Gleeson ◽  
Valerie Wilson ◽  
Thomas E. Cox ◽  
Seema D. Sharma ◽  
Kate Smith-Jackson ◽  
...  

2021 ◽  
pp. 1753495X2110199
Author(s):  
Mehmet Nuri Duran ◽  
Fatma Beyazit ◽  
Mesut Erbaş ◽  
Onur Özkavak ◽  
Celal Acar ◽  
...  

Pregnancy‐associated atypical haemolytic uraemic syndrome is a rare and potentially lethal complement-mediated disorder. It can mimic preeclampsia, gestational hypertension, thrombotic thrombocytopenic purpura and hemolysis, elevated liver enzymes and low platelets syndrome. Thus, it can be hard to distinguish pregnancy‐associated atypical haemolytic uraemic syndrome from other causes in peri/post-partum women presenting with features of microangiopathic haemolytic anemia, thrombocytopenia and acute kidney injury. We present a case of a 35-year-old woman in her third pregnancy at 32 weeks’ gestation who underwent caesarean section due to fetal distress. She developed severe renal impairment, thrombocytopenia and neurologic symptoms within 24 hours after delivery. A diagnosis of pregnancy‐associated atypical haemolytic uraemic syndrome was provided, and treatment with plasma therapy followed by eculizumab was initiated. A rapid improvement of both clinical and laboratory parameters was observed. This case demonstrates the significance of early initiation of anti-complement therapy to prevent irreversible renal damage and possible death in women with pregnancy‐associated atypical haemolytic uraemic syndrome.


2010 ◽  
Vol 47 (13) ◽  
pp. 2291-2292 ◽  
Author(s):  
David Kavanagh ◽  
Isabel Y. Pappworth ◽  
Pietro Roversi ◽  
John S. Tapson ◽  
Iain Moore ◽  
...  

2017 ◽  
Vol 10 (2) ◽  
pp. 263-265
Author(s):  
James Collett ◽  
Amali Mallawaarachchi ◽  
Eddy Fischer ◽  
Muralikrishna Gangadharan Komala ◽  
Kamal Sud ◽  
...  

2017 ◽  
Vol 103 (3) ◽  
pp. 285-291 ◽  
Author(s):  
Patrick R Walsh ◽  
Sally Johnson

Haemolytic uraemic syndrome (HUS), comprising microangiopathic haemolytic anaemia, thrombocytopaenia and acute kidney injury, remains the leading cause of paediatric intrinsic acute kidney injury, with peak incidence in children aged under 5 years. HUS most commonly occurs following infection with Shiga toxin-producing Escherichia coli (STEC-HUS). Additionally, HUS can occur as a result of inherited or acquired dysregulation of the alternative complement cascade (atypical HUS or aHUS) and in the setting of invasive pneumococcal infection. The field of HUS has been transformed by the discovery of the central role of complement in aHUS and the dawn of therapeutic complement inhibition. Herein, we address these three major forms of HUS in children, review the latest evidence for their treatment and discuss the management of STEC infection from presentation with bloody diarrhoea, through to development of fulminant HUS.


2013 ◽  
Vol 68 (1) ◽  
pp. 9-14 ◽  
Author(s):  
A Massart ◽  
S Golmarvi ◽  
S Hachimi-Idrissi ◽  
E Broeders ◽  
Y Tournay ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document